Dr. Allen L. Hunt

Family Medicine
3910 Village Dr, 
Lincoln, NE 
3910 Village Dr, 
Lincoln, NE 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Allen Hunt is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. His top areas of expertise are Asthma and Tracheitis.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Licenses
Family Medicine in NE
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Medica
  • EPO
  • HMO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

3910 Village Dr, Lincoln, NE 68516

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 1, First-in-Human, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SM17 When Administered Intravenously as a Single Ascending Dose in Healthy Subjects (Part A) and as Multiple Ascending Doses in Healthy Subjects (Part B)
A Phase 1, First-in-Human, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SM17 When Administered Intravenously as a Single Ascending Dose in Healthy Subjects (Part A) and as Multiple Ascending Doses in Healthy Subjects (Part B)
Enrollment Status: Completed
Publish Date: September 27, 2024
Intervention Type: Other, Biological
Study Phase: Phase 1
A Phase 1, Open-Label Study to Evaluate the Effect of Itraconazole and Mefenamic Acid on the Single-Dose Pharmacokinetic Profile of Soticlestat in Healthy Participants
A Phase 1, Open-Label Study to Evaluate the Effect of Itraconazole and Mefenamic Acid on the Single-Dose Pharmacokinetic Profile of Soticlestat in Healthy Participants
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Double-blind, Randomized, Placebo-controlled, Sequential, Single, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Parameters of Subcutaneous Injections of GZR18 in Healthy Subjects
A Double-blind, Randomized, Placebo-controlled, Sequential, Single, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Parameters of Subcutaneous Injections of GZR18 in Healthy Subjects
Enrollment Status: Completed
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 1
A Phase I, Open-Label, Randomized, Three-Period, Three-Sequence Crossover Study of the Effects of Co-administration of Intravenous VLX-1005 With Argatroban on Pharmacokinetics, Pharmacodynamics and Safety in Healthy Adult Subjects
A Phase I, Open-Label, Randomized, Three-Period, Three-Sequence Crossover Study of the Effects of Co-administration of Intravenous VLX-1005 With Argatroban on Pharmacokinetics, Pharmacodynamics and Safety in Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: January 11, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CU06-1004 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CU06-1004 in Healthy Subjects
Enrollment Status: Completed
Publish Date: July 21, 2022
Intervention Type: Drug
Study Drug: CU06-1004
Study Phase: Phase 1
A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Intravenous VLX-1005 in Healthy Subjects
A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Intravenous VLX-1005 in Healthy Subjects
Enrollment Status: Completed
Publish Date: April 28, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of Single Ascending Doses of Subcutaneous CDX-0159 to Assess the Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of Single Ascending Doses of Subcutaneous CDX-0159 to Assess the Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
Enrollment Status: Completed
Publish Date: January 21, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Study to Assess Absolute Bioavailability of TAK-994 and to Characterize Mass Balance, Pharmacokinetics, Absorption, Metabolism, and Excretion of [14C]TAK-994 in Male Healthy Subjects
A Phase 1 Study to Assess Absolute Bioavailability of TAK-994 and to Characterize Mass Balance, Pharmacokinetics, Absorption, Metabolism, and Excretion of [14C]TAK-994 in Male Healthy Subjects
Enrollment Status: Completed
Publish Date: June 29, 2021
Intervention Type: Drug
Study Phase: Phase 1
Exploratory Microdose Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds
Exploratory Microdose Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Early Phase 1
View 8 Less Clinical Trials

9 Total Publications

The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects.
The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects.
Journal: Diabetes, obesity & metabolism
Published: November 04, 2024
Similar Doctors
Expertise in
13
conditions
Dr. Nathan P. Denell
Family Medicine
Expertise in
13
conditions
Dr. Nathan P. Denell
Family Medicine

South Lincoln Family Physicians PC

3201 Pioneers Blvd, Suite 304, 
Lincoln, NE 
 (1.2 miles away)
402-483-2987
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nathan Denell is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. Dr. Denell is highly rated in 13 conditions, according to our data. His top areas of expertise are High Cholesterol, Familial Combined Hyperlipidemia, Xanthoma, and Cirrhosis. Dr. Denell is currently accepting new patients.

Expertise in
28
conditions
Dr. Steven J. Saathoff
Family Medicine
Expertise in
28
conditions
Dr. Steven J. Saathoff
Family Medicine

Fallbrook Family Health Center

755 Fallbrook Blvd, Suite 100, 
Lincoln, NE 
 (9.2 miles away)
402-441-3575
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Saathoff is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. Dr. Saathoff is highly rated in 28 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Osteomyelitis in Children, High Cholesterol, and Familial Combined Hyperlipidemia. Dr. Saathoff is currently accepting new patients.

Expertise in
8
conditions
Dr. Peter M. Morin
Family Medicine
Expertise in
8
conditions
Dr. Peter M. Morin
Family Medicine

Family Physicians Group, PC

770 N Cotner Blvd, Suite 205, 
Lincoln, NE 
 (4.9 miles away)
402-467-4661
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Peter Morin is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. Dr. Morin is highly rated in 8 conditions, according to our data. His top areas of expertise are Sitosterolemia, Fructose-1,6-Bisphosphatase Deficiency, High Cholesterol, and Hypertension. Dr. Morin is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hunt's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile